Denosumab vs Zoledronic Acid Treatment in Post-Menopausal Breast Cancer: A 2-year Prospective Observational Study
Published: 16 February 2021| Version 1 | DOI: 10.17632/3xjhghs24g.1
Contributor:
Kristian Buch-Larsen
Description
Source Data with BMD and lab result data - contact authors for further information
Files
Categories
Breast Cancer